How GLP-1 direct-to-consumer programs are distorting utilization trends
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to grow across obesity and metabolic disease, but the way patients access these therapies is changing in ways that complicate traditional research approac...